Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

If I were a statistician tucked away in an NHS backroom, I might well curse the day the health service was founded. There, on ...

Donanemab: Everything we know about the latest Alzheimer’s drug rejected by the NHS - Donanemab and another new drug for ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

There have been many promising leads for an Alzheimer's vaccine but new treatments have been slow to merge. Researchers at ...

Donanemab, the most effective treatment yet for the disease, has been banned on the health service despite regulators ...

Health spending watchdog said costs could not justify benefits after treatment slowed cognitive decline by around four to ...

The Alzheimer's Society Cymru has responded to the approval of a new Alzheimer's treatment. The Medicines and Healthcare products Regulatory Agency (MHRA) announced on Wednesday, October 23, that it ...

UK MHRA grants marketing approval to Lilly's Kisunla to treat mild cognitive impairment and mild dementia due to Alzheimer's disease: Indianapolis Thursday, October 24, 2024, 09:0 ...